BioSpace News Archive

Pharm Country

Outlook Therapeutics® Doses First Subject in NORSE EIGHT

Outlook Therapeutics, Inc. today announced that the first subject has been dosed in the NORSE EIGHT clinical trial evaluating ONS-5010 in neovascular age-related macular degeneration (wet AMD) patients.

January 31, 2024
·
6 min read
Biotech Bay

CymaBay Therapeutics to Participate in Upcoming Investment Conferences

CymaBay Therapeutics, Inc. today announced that members of its management team will participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference, February 7-8, in New York, NY.

January 31, 2024
·
1 min read
Launching our most comprehensive test and expanding into new global markets

Genetic Technologies Limited, is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with its inventive strategy for early disease detection and personalized wellness is pleased to share Business update for the quarter ending 31 December 2023.

January 31, 2024
·
7 min read
Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics

Halia Therapeutics announced the completion of a $30 million Series C financing. The financing was led by Todd Pedersen, with continued participation from existing investors.

January 31, 2024
·
4 min read
BioMidwest

Study Unlocks New Hope in the Battle Against Male Infertility

A groundbreaking study conducted by researchers at the University of California Los Angeles and MicroGenDX unveils a potential link between bacterial profiles and male infertility.

January 31, 2024
·
3 min read
BioMidwest

Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177

Eckert & Ziegler and Nucleus RadioPharma signed extensive supply agreements for major therapeutic radioisotopes.

January 31, 2024
·
3 min read
Pharm Country

Protara Therapeutics to Participate in Upcoming Investor Conferences - January 31, 2024

Protara Therapeutics, Inc. today announced that management will participate in the following investor conferences.

January 31, 2024
·
1 min read
Drug Development

Neurimmune to regain global rights to brain amyloid depleter for the treatment of Alzheimer’s disease

Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid.

January 31, 2024
·
2 min read
Genetown

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024

Rhythm Pharmaceuticals, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, February 22, 2024 to report its fourth quarter and full year 2023 financial results and provide a corporate update.

January 31, 2024
·
9 min read
Pharm Country

Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Phathom Pharmaceuticals, Inc. announced today that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024, at 1:30 p.m. ET.

January 31, 2024
·
1 min read